Aetna BRCA testing policy bulletin not a change, says William Blair William Blair says shares of Myriad Genetics (MYGN) dropped 2% Friday after Aetna (AET) issued a clinical policy bulletin update for BRCA testing that changed the word "Myriad" to "Laboratory." The firm believes the bulletin does not represent a change to the status quo since a number of labs now offer BRCA testing. William Blair keeps an Outperform rating on Myriad.
News For MYGN;AET From The Last 14 Days
Check below for free stories on MYGN;AET the last two weeks.